A detailed history of Montag A & Associates Inc transactions in Boston Scientific Corp stock. As of the latest transaction made, Montag A & Associates Inc holds 15,800 shares of BSX stock, worth $1.43 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
15,800
Previous 16,300 3.07%
Holding current value
$1.43 Million
Previous $1.26 Million 5.5%
% of portfolio
0.06%
Previous 0.06%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$72.96 - $84.0 $36,480 - $42,000
-500 Reduced 3.07%
15,800 $1.32 Million
Q2 2024

Jul 31, 2024

BUY
$67.33 - $77.71 $115,336 - $133,117
1,713 Added 11.74%
16,300 $1.26 Million
Q4 2023

Feb 07, 2024

BUY
$48.64 - $57.81 $573,319 - $681,406
11,787 Added 420.96%
14,587 $843,000
Q3 2023

Nov 09, 2023

BUY
$50.19 - $54.68 $4,416 - $4,811
88 Added 3.24%
2,800 $147,000
Q4 2022

Feb 02, 2023

BUY
$39.56 - $47.22 $8,386 - $10,010
212 Added 8.48%
2,712 $125,000
Q4 2020

Feb 12, 2021

BUY
$33.15 - $41.97 $82,875 - $104,925
2,500 New
2,500 $90,000
Q1 2020

May 06, 2020

SELL
$25.83 - $45.71 $125,921 - $222,836
-4,875 Closed
0 $0
Q4 2019

Feb 05, 2020

SELL
$37.87 - $45.37 $4,733 - $5,671
-125 Reduced 2.5%
4,875 $220,000
Q2 2019

Aug 06, 2019

SELL
$34.91 - $42.98 $52,364 - $64,469
-1,500 Reduced 23.08%
5,000 $215,000
Q1 2019

May 01, 2019

SELL
$32.91 - $40.75 $296,189 - $366,750
-9,000 Reduced 58.06%
6,500 $249,000
Q4 2018

Feb 06, 2019

SELL
$31.73 - $39.04 $836,942 - $1.03 Million
-26,377 Reduced 62.99%
15,500 $548,000
Q2 2018

Aug 08, 2018

SELL
$26.84 - $34.32 $89,914 - $114,972
-3,350 Reduced 7.41%
41,877 $1.37 Million
Q2 2018

Aug 01, 2018

BUY
$26.84 - $34.32 $1.21 Million - $1.55 Million
45,227 New
45,227 $1.48 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Montag A & Associates Inc Portfolio

Follow Montag A & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Montag A & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Montag A & Associates Inc with notifications on news.